News
ICNAS/University of Coimbra granted with first EU marketing authorization for the distribution of cyclotron produced Gallium-68
ICNAS/University of Coimbra granted with first EU marketing authorization for the distribution of cyclotron produced Gallium-68 The Institute of Nuclear […]
See moreIBA and SCK CEN join forces to enable production of Actinium-225
Collaboration marks first step in evaluating the potential of the rapidly growing theranostics market Louvain-La-Neuve, Belgium, 15 September 2021 – […]
See moreIBA Reports Half Year 2021 Results
25% SALES GROWTH AND STRONG IMPROVEMENT IN REBIT LINKED TO INCREASED ACTIVITY AND ACCELERATED BACKLOG CONVERSION STRONG BALANCE SHEET WITH […]
See moreRigging of the Cyclone® KIUBE for Inkor Technologies Co.
The Cyclone® KIUBE has reached its final position at Junqui in Foshan, China. The new radiopharmacy will be equipped with […]
See moreA New Cyclone® KIUBE to be installed in Mogi das Cruzes, Brazil
R2IBF signed a contract with IBA for the company's new plant in Mogi das Cruzes to have the most modern […]
See moreThe Cyclone® KIUBE passed its acceptance test at Sichuan Province Cyclotron Medical Science Co., Ltd.
The new radiopharmacy will now be start its production of F-18 compounds using the Cyclone® KIUBE and the Synthera® + […]
See moreThe Cyclone® 70 for the Institute of Basic Science in Korea passed the Factory Acceptance Test.
The FAT confirms the machine is compliant with its specifications. The Cyclone® 70 will now be disassembled to be packed and […]
See moreOur Newsletter is out! Issue 27, summer2021
The launch of the Cyclone® IKON, Cyclotron riggings, new members of the team, Synthera® installations, webinars,... read it all in our summer […]
See moreIBA Launches versatile high-energy new Cyclotron
IBA leverages 35 years of experience and innovation in the new Cyclone® IKON with enhanced availability of theranostic radiopharmaceuticals […]
See more